Kiro
Digital medicine company integrating advanced computational methods with biological innovations to optimize clinical development and healthcare delivery.
Website
https://www.kiro.bioLocation
Paris, France
Founded
2020
Investors
1
Categories
digital-medicine, ai, healthcare, pharma-services, clinical-trials
Notes
Kiro is a digital medicine company focused on leveraging artificial intelligence and computational biology to transform drug development and healthcare. The company sits at the intersection of biology, data science, and computation to deliver innovative solutions for the pharmaceutical industry.
As a portfolio company of Sofinnova Partners' Digital Medicine Strategy, Kiro is part of a new wave of companies applying digital technologies to improve healthcare outcomes and drug development efficiency.
Team
- Information on leadership team pending further research
Additional Research Findings
- Founded around 2020
- Headquartered in Paris, France
- Portfolio company of Sofinnova Partners
- Part of Sofinnova Digital Medicine Strategy
- Focus on AI-driven healthcare and clinical development solutions
- Works at the intersection of biology, data, and computation
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Sofinnova Partners | Paris, France | biotech-focused | seedseries-a+3 | 23 |